Rhenium Nanoliposome
Showing 1 - 12 of 12
Glioma Trial (Retreatment Rhenium Liposome)
Not yet recruiting
- Glioma
- Retreatment Rhenium Liposome
- (no location specified)
Jul 12, 2022
Glioma Trial in Dallas, Houston, San Antonio (Rhenium Liposome Treatment)
Recruiting
- Glioma
- Rhenium Liposome Treatment
-
Dallas, Texas
- +2 more
Nov 3, 2021
Non-melanoma Skin Cancer Trial in Sydney, Tugun (Rhenium-SCT)
Recruiting
- Non-melanoma Skin Cancer
- Rhenium-SCT
-
Sydney, New South Wales, Australia
- +1 more
Mar 30, 2022
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia, Refractory Trial in New York, Hershey, Charlottesville (Ceramide
Not yet recruiting
- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia, Refractory
- Ceramide NanoLiposome (Ceraxa)
-
New York, New York
- +2 more
Jan 15, 2021
Prostate Cancer Metastatic to Bone Trial in Amsterdam (Radium-223 chloride, Rhenium-188-HEDP)
Active, not recruiting
- Prostate Cancer Metastatic to Bone
- Radium-223 chloride
- Rhenium-188-HEDP
-
Amsterdam, NetherlandsVU University Medical Center
Nov 16, 2020
Cancer, Carcinoma, Solid Tumors Trial in Baltimore, Charleston, Charlottesville (Ceramide NanoLiposome)
Unknown status
- Cancer
- +3 more
- Ceramide NanoLiposome
-
Baltimore, Maryland
- +2 more
Feb 26, 2019
Small Cell Lung Cancer (SCLC), Neuroendocrine (NE) Tumors, Large Cell Neuroendocrine (NE) Tumors Trial in Baltimore (Rhenium Re
Withdrawn
- Small Cell Lung Cancer (SCLC)
- +2 more
- Rhenium Re 188-P2045
-
Baltimore, MarylandUniversity of Maryland Marlene & Stewart Greenebaum Cancer Cente
Oct 15, 2019
Lung Tumors, NSCLC, Carcinoma, Small Cell Trial in Iowa City, Baltimore (Rhenium (Re 188 P2045, BAY86-5284))
Unknown status
- Lung Neoplasms
- +3 more
- Rhenium (Re 188 P2045, BAY86-5284)
-
Iowa City, Iowa
- +1 more
Jan 9, 2019
NSCLC Trial (hMAb BIWA 4)
Completed
- Carcinoma, Non-Small-Cell Lung
- hMAb BIWA 4
- (no location specified)
Jul 29, 2014
Head and Neck Tumors Trial (99mTc - labelled hMAb BIWA 4, 186 Re - labelled hMAb BIWA 4, unlabelled hMAb BIWA 4 - low dose)
Completed
- Head and Neck Neoplasms
- 99mTc - labelled hMAb BIWA 4
- +4 more
- (no location specified)
Jul 29, 2014